Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.

Harada K, Ferdous T, Cui D, Kuramitsu Y, Matsumoto T, Ikeda E, Okano H, Ueyama Y.

BMC Cancer. 2016 Jul 27;16:548. doi: 10.1186/s12885-016-2416-9.

2.

Cancer Stem Cell Hierarchy in Glioblastoma Multiforme.

Bradshaw A, Wickremsekera A, Tan ST, Peng L, Davis PF, Itinteang T.

Front Surg. 2016 Apr 15;3:21. doi: 10.3389/fsurg.2016.00021. eCollection 2016. Review.

3.

Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA.

Zhang C, Samanta D, Lu H, Bullen JW, Zhang H, Chen I, He X, Semenza GL.

Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2047-56. doi: 10.1073/pnas.1602883113. Epub 2016 Mar 21.

PMID:
27001847
4.

KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis.

Yan Y, Li Z, Kong X, Jia Z, Zuo X, Gagea M, Huang S, Wei D, Xie K.

Cancer Res. 2016 Apr 15;76(8):2419-31. doi: 10.1158/0008-5472.CAN-15-1691. Epub 2016 Feb 15.

PMID:
26880805
5.

JNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.

Neganova I, Shmeleva E, Munkley J, Chichagova V, Anyfantis G, Anderson R, Passos J, Elliott DJ, Armstrong L, Lako M.

Stem Cells. 2016 May;34(5):1198-212. doi: 10.1002/stem.2327. Epub 2016 Mar 4.

6.

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.

Kaur S, Elkahloun AG, Singh SP, Chen QR, Meerzaman DM, Song T, Manu N, Wu W, Mannan P, Garfield SH, Roberts DD.

Oncotarget. 2016 Mar 1;7(9):10133-52. doi: 10.18632/oncotarget.7100.

7.

Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.

Marcotte R, Sayad A, Brown KR, Sanchez-Garcia F, Reimand J, Haider M, Virtanen C, Bradner JE, Bader GD, Mills GB, Pe'er D, Moffat J, Neel BG.

Cell. 2016 Jan 14;164(1-2):293-309. doi: 10.1016/j.cell.2015.11.062.

PMID:
26771497
8.

Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake.

Nakajima K, Cui Z, Li C, Meister J, Cui Y, Fu O, Smith AS, Jain S, Lowell BB, Krashes MJ, Wess J.

Nat Commun. 2016 Jan 8;7:10268. doi: 10.1038/ncomms10268. Erratum in: Nat Commun. 2016;7:11019.

9.

Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.

Ryoo IG, Lee SH, Kwak MK.

Oxid Med Cell Longev. 2016;2016:2428153. doi: 10.1155/2016/2428153. Epub 2015 Nov 22. Review.

10.

Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.

Yuan F, Zhang YH, Wan S, Wang S, Kong XY.

Biomed Res Int. 2015;2015:623121. doi: 10.1155/2015/623121. Epub 2015 Nov 3.

11.

The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.

Li W, Liu M, Su Y, Zhou X, Liu Y, Zhang X.

Oncotarget. 2015 Dec 29;6(42):44480-94. doi: 10.18632/oncotarget.6256.

12.

Common stemness regulators of embryonic and cancer stem cells.

Hadjimichael C, Chanoumidou K, Papadopoulou N, Arampatzi P, Papamatheakis J, Kretsovali A.

World J Stem Cells. 2015 Oct 26;7(9):1150-84. doi: 10.4252/wjsc.v7.i9.1150. Review.

13.

Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.

Park SY, Kim MJ, Park SA, Kim JS, Min KN, Kim DK, Lim W, Nam JS, Sheen YY.

Oncotarget. 2015 Nov 10;6(35):37526-43. doi: 10.18632/oncotarget.6063.

14.

Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras.

Zhou F, Krishnamurthy J, Wei Y, Li M, Hunt K, Johanning GL, Cooper LJ, Wang-Johanning F.

Oncoimmunology. 2015 May 26;4(11):e1047582. eCollection 2015 Nov.

15.

Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis.

Hu D, Gur M, Zhou Z, Gamper A, Hung MC, Fujita N, Lan L, Bahar I, Wan Y.

Nat Commun. 2015 Sep 30;6:8419. doi: 10.1038/ncomms9419.

16.

The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer.

Voutsadakis IA.

Breast Cancer (Dove Med Press). 2015 Sep 7;7:303-19. doi: 10.2147/BCTT.S71163. eCollection 2015. Review.

17.

Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione.

Jia Y, Zhang C, Zhou L, Xu H, Shi Y, Tong Z.

Onco Targets Ther. 2015 Aug 28;8:2319-27. doi: 10.2147/OTT.S88661. eCollection 2015.

18.

Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells.

Ruiz S, Lopez-Contreras AJ, Gabut M, Marion RM, Gutierrez-Martinez P, Bua S, Ramirez O, Olalde I, Rodrigo-Perez S, Li H, Marques-Bonet T, Serrano M, Blasco MA, Batada NN, Fernandez-Capetillo O.

Nat Commun. 2015 Aug 21;6:8036. doi: 10.1038/ncomms9036.

19.

Optimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells.

Jabbari E, Sarvestani SK, Daneshian L, Moeinzadeh S.

PLoS One. 2015 Jul 13;10(7):e0132377. doi: 10.1371/journal.pone.0132377. eCollection 2015.

20.
Items per page

Supplemental Content

Write to the Help Desk